Estimaciones de analistas de Wall Street para MetaVia Inc. (MTVA): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-05 | $-0.73 | ||
| 2026-08-06 | $-0.90 | $-0.82 | -9.8% |
| 2026-05-14 | $-0.79 | $-0.76 | -3.9% |
| 2026-03-26 | $1.01 | $-2.06 | +149.0% |
| 2025-11-06 | $-1.54 | $-2.86 | +46.2% |
| 2025-08-07 | $-2.86 | $-3.52 | +18.8% |
| 2025-05-14 | $-3.96 | $-6.27 | +36.8% |
| 2025-03-27 | $-1.76 | $-0.72 | -144.4% |
Ratios de valoración
| Precio / Valor contable | 1.34 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | 0 | 0 | 0 | 0 | $67000 | $72000 | $28000 | $7000 | $24000 | $19000 |
| Beneficio Bruto | 0 | 0 | 0 | 0 | -$67000 | -$72000 | -$28000 | -$7000 | -$24000 | -$19000 |
| I+D | $8.7M | $22.7M | $13.9M | $17.5M | $21.9M | $6.5M | $2.8M | $9.2M | $21.5M | $6.8M |
| Generales y Administrativos | $6.0M | $10.4M | $1.6M | $2.7M | $7.8M | $8.8M | $8.6M | $6.7M | $7.3M | $6.9M |
| Gastos Operativos | $14.7M | $33.1M | $15.5M | $20.2M | $29.7M | $15.3M | $19.6M | $15.9M | $28.8M | $13.7M |
| Beneficio Operativo | -$14.7M | -$33.1M | -$15.5M | -$20.2M | -$29.7M | -$15.3M | -$19.6M | -$15.9M | -$28.8M | -$13.7M |
| EBITDA | -$14.7M | -$33.1M | -$15.5M | -$20.2M | -$29.7M | -$15.2M | -$11.8M | -$12.5M | -$27.6M | -$13.0M |
| Gastos por Intereses | 0 | $286000 | $40000 | $22000 | 0 | 0 | $2.2M | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$14.6M | -$33.4M | -$15.5M | -$21.3M | -$29.7M | -$15.3M | -$14.0M | -$12.5M | -$27.6M | -$13.0M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$14.6M | -$33.4M | -$15.5M | -$21.3M | -$29.7M | -$15.3M | -$14.0M | -$12.5M | -$27.6M | -$13.0M |
| BPA | $-106454.37 | $-213180.00 | $-112860.00 | $-10771.20 | $-4831.20 | $-1742.40 | $-477.84 | $-27.06 | $-39.16 | $-7.35 |
| BPA Diluido | $-106454.37 | $-213180.00 | $-112860.00 | $-10771.20 | $-4831.20 | $-1742.40 | $-477.84 | $-27.06 | $-39.16 | $-7.35 |
| Acciones en Circulación (Diluidas) | $140 | $157 | $209 | $1979 | $6143 | $8767 | $29246 | $461009 | $705193 | $1.8M |
Precio
| Precio | $1.54 |
| Capitalización | $3M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: CASI · CLGN · CLSD · ENLV · KLTO · LSTA · NCNA
Explorar sector: Healthcare · Biotechnology
Más secciones de MTVA: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones